Gut-Brain Axis Therapeutics Inc.

Gut-Brain Axis Therapeutics Inc.Gut-Brain Axis Therapeutics Inc.Gut-Brain Axis Therapeutics Inc.

Heal the gut - Heal the brain

Gut-Brain Axis Therapeutics Inc.

Gut-Brain Axis Therapeutics Inc.Gut-Brain Axis Therapeutics Inc.Gut-Brain Axis Therapeutics Inc.

Heal the gut - Heal the brain

Our Mission

Heal the Gut - Heal the Brain

We are dedicated to innovative research to develop new products to improve the gut microbiota and gut health, and thereby improve brain health and overall functioning.


Our initial focus is on developing Microbiota Transplant Therapy for Autism and Pitt Hopkins Syndrome.


 

About Us

James B. Adams, PhD

Rosa Krajmalnik-Brown, PhD

Rosa Krajmalnik-Brown, PhD

Dr. Adams is the president of GBAT, 

and leads the clinical trials.

Rosa Krajmalnik-Brown, PhD

Rosa Krajmalnik-Brown, PhD

Rosa Krajmalnik-Brown, PhD

Dr. Krajmalnik-Brown leads the microbiome analysis and co-leads the clinical trials.

Alexander Khoruts, MD

Alexander Khoruts, MD

Alexander Khoruts, MD

Dr. Khoruts leads the healthy donor program and co-leads the microbiota production.

Michael Sadowsky, PhD

Alexander Khoruts, MD

Alexander Khoruts, MD

Dr. Sadowsky co-leads the microbiota production.

Call for Investors

GBAT is currently holding private discussions with accredited investors.

Definition of an accredited investor

1) Annual income of at least $200,000/year (or $300,000/year with spouse) for last 2 years and expected for future

OR: 

2) Net worth of at least $1 million excluding primary residence


For more information, please visit https://www.sec.gov/education/capitalraising/building-blocks/accredited-investor

We invite you to help us improve the lives of children and adults with autism and Pitt Hopkins!

Sign up for our confidential investor contact list at: https://forms.gle/7CkmyvST1fBCdd5D8

Questions about Gut-Brain Axis Therapeutics Inc.? Email us at james@gutbrainaxistherapeutics.com

Frequently Asked Questions

Two of the primary publications are available for free at:

 

  • Microbiota Transfer Therapy alters gut ecosystem and improves gastrointestinal and autism symptoms: an open-label study - PubMed (nih.gov)
  • Long-term benefit of Microbiota Transfer Therapy on autism symptoms and gut microbiota - PubMed (nih.gov)


More information is available at http://autism.asu.edu


Our next clinical trials will be at Arizona State University and other locations.  You can sign up to be contacted about future studies at http://autism.asu.edu.


Contact Us

Drop us a line!

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Gut-Brain Axis Therapeutics, Inc.

Gut-Brain Axis Therapeutics

Copyright © 2023 Gut-Brain Axis Therapeutics - All Rights Reserved.

Powered by GoDaddy

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept